Background The relationship between coronavirus disease 2019 (COVID-19) vaccination
and long COVID has not been firmly established. We conducted a systematic review and …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has infected over 600 million individuals and caused …

Importance The BNT162b2 two-dose vaccine (BioNTech/Pfizer) has high effectiveness that
wanes within several months. The third dose is effective in mounting a significant immune …

SARS-CoV-2 has resulted in high levels of morbidity and mortality world-wide, and severe
complications can occur in older populations. Humoral immunity induced by authorized …

SARS‐CoV‐2 vaccines have contributed to the control of COVID‐19 in some parts of the
world. However, the constant emergence of variants of concern (VOCs) challenges the …

Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a …

The SARS-CoV-2 coronavirus has caused a global pandemic. Despite the initial success of
vaccines at preventing infection, genomic variation has led to the proliferation of variants …

Annually, seasonal influenza is responsible for millions of infections and hundreds of
thousands of deaths. The current method for managing influenza is vaccination using a …

Vaccination against SARS-CoV-2 using mRNA-based vaccines has been highly
recommended for fragile subjects, including myelofibrosis patients (MF). Available data on …

In malaria endemic countries, coinfections and cotransmissions of different viral pathogens
are widely reported. Prior studies have shown that malaria can trigger the Epstein-Barr virus …